abagovomab 33
abciximab 28
abituzumab 17
abrilumab 15
actoxumab 25
adalimumab 9
aducanumab 11
afasevikumab 7
alacizumab_pegol 6
alemtuzumab 38
alirocumab 14
amatuximab 40
andecaliximab 25
anifrolumab 25
anrukinzumab 14
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 14
ascrinvacumab 16
atezolizumab 10
atinumab 17
avelumab 14
basiliximab 33
bavituximab 28
begelomab 26
benralizumab 22
bevacizumab_beta 16
bezlotoxumab 25
bimagrumab 21
bleselumab 28
blinatumomab 33
blosozumab 33
bococizumab 24
brazikumab 17
brentuximab_vedotin 27
briakinumab 15
brodalumab 16
brolucizumab 20
brontictuzumab 26
burosumab 27
cabiralizumab 26
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 39
carlumab 18
carotuximab 9
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 22
cetiximab 33
citatuzumab_bogatox 25
cixutumumab 37
clivatuzumab_tetraxetan 26
codrituzumab 26
conatumumab 21
concizumab 17
crenezumab 19
crizanlizumab 23
crotedumab 22
dacetuzumab 23
daclizumab 22
dalotuzumab 33
dapirolizumab_pegol 25
daratumumab 13
dectrekumab 9
demcizumab 29
denosumab 10
depatuxizumab 27
depatuxizumab_mafodotin 27
dezamizumab 21
dinutuximab 34
diridavumab 26
domagrozumab 11
drozitumab 18
duligotuzumab 20
durvalumab 13
dusigitumab 31
efalizumab 33
efungumab 18
eldelumab 17
elezanumab 28
elgemtumab 5
elotuzumab 15
emactuzumab 23
emapalumab 19
emibetuzumab 23
enavatuzumab 24
enfortumab_vedotin 12
enoblituzumab 18
enokizumab 29
enoticumab 21
ensituximab 33
eptinezumab 10
erenumab 28
etaracizumab 12
etrolizumab 24
evinacumab 17
evolocumab 20
farletuzumab 0
fasinumab 24
fezakinumab 24
fibatuzumab 16
ficlatuzumab 29
firivumab 27
flanvotumab 19
fletikumab 37
foralumab 15
foravirumab 15
fremanezumab 24
fresolimumab 15
fulranumab 16
futuximab 19
galcanezumab 15
ganitumab 30
gantenerumab 15
gemetuzumab 30
gemtuzumab2 29
gemtuzumab 16
gevokizumab 24
girentuximab 29
glembatumumab 26
glembatumumab_vedotin 26
guselkumab 29
ibalizumab 25
ibritumomab 32
icrucumab 15
idarucizumab 32
ifabotuzumab 16
imalumab 14
imgatuzumab 25
inclacumab 16
indatuximab_ravtansin 30
indusatumab 21
inebilizumab 25
intetumumab 13
iodine_girentuximab 23
ipilimumab 4
iratumumab 23
isatuximab 29
itolizumab 20
ixekizumab 24
labetuzumab_govitecan 25
lambrolizumab 28
lampalizumab 26
lanadelumab 19
landogrozumab 20
laprituximab 25
lebrikizumab 30
lendalizumab 31
lenzilumab 23
lifastuzumab_vedotin 16
ligelizumab 24
lilotomab 31
lirilumab 26
lodelcizumab 23
lokivetmab 12
lorvotuzumab_mertansin 15
lucatumumab 30
lumretuzumab 22
lupartumab 16
lutikizumab 12
margetuximab 31
milatuzumab 22
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 44
mogamulizumab 21
monalizumab 23
motavizumab 31
moxetumomab_pasudotox 14
namilumab 21
naratuximab 36
naratuximab_emtansin 36
narnatumab 16
navicixizumab2 28
navicixizumab 29
navivumab 18
necitumumab 23
nemolizumab 34
nesvacumab 16
nivolumab 17
obiltoxaximab 17
obinutuzumab 31
ocaratuzumab 22
ofatumumab 14
olaratumab 25
olokizumab 21
omalizumab 20
onartuzumab 24
ontuxizumab 19
opicinumab 13
orticumab 10
otelixizumab 26
oxelumab 8
ozanezumab 24
pamrevlumab 7
panobacumab 21
parsatuzumab 29
pasotuxizumab 18
pateclizumab 17
patritumab 31
pembrolizumab 28
perakizumab 20
pidilizumab 16
pinatuzumab_vedotin 17
plozalizumab 13
pogalizumab 28
polatuzumab_vedotin 19
ponezumab 30
prezalumab 14
pritoxaximab 32
quilizumab 16
racotumomab 25
radretumab 11
ralpancizumab 29
ramucirumab 13
ranevetmab 29
ranibizumab 13
refanezumab 18
remtolumab 10
rilotumumab 28
rinucumab 20
risankizumab 34
rituximab 20
rivabazumab 23
robatumumab 19
roledumab 17
romosozumab 22
rontalizumab 26
rosmantuzumab 23
rozanolixizumab 18
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 27
sapelizumab 23
sarilumab 10
secukinumab 19
seribantumab 17
setoxaximab 36
sifalimumab 15
siltuximab 12
simtuzumab 31
sirukumab 9
solanezumab 26
solitomab 23
stamulumab 25
suptavumab 25
suvizumab 20
tabalumab 17
tadocizumab 21
tamtuvetmab 32
tanezumab 26
tarextumab 10
tavolixizumab 14
telisotuzumab 28
teplizumab 20
tesidolumab 27
tezepelumab 29
tigatuzumab 13
tildrakizumab 22
timolumab 12
tisotumab 12
tosatoxumab 29
tositumomab 29
tralokinumab 31
trastuzumab 26
tregalizumab 19
trevogrumab 8
ublituximab 30
urelumab 29
ustekinumab 25
utomilumab 25
vadastuximab 24
vadastuximab_talirin 24
vandortuzumab_vedotin 21
vantictumab 25
vanucizumab2 16
vanucizumab 30
varlilumab 18
vatelizumab 24
vedolizumab 24
veltuzumab 24
vesencumab 8
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 30
xentuzumab 18
zatuximab 44
